Kura Oncology (KURA) Return on Capital Employed (QoQ) (2011 - 2026)
Kura Oncology (KURA) Return on Capital Employed (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Kura Oncology | 952.56 Mn | 952.56 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -108.00 |
| Dec 31, 2025 | -4,060.00 |
| Sep 30, 2025 | -369.00 |
| Jun 30, 2025 | 134.00 |
| Mar 31, 2025 | -243.00 |
| Dec 31, 2024 | 3,391.00 |
| Sep 30, 2024 | -1,375.00 |
| Jun 30, 2024 | -938.00 |
| Mar 31, 2013 | -82.00 |
| Dec 31, 2012 | -244.00 |
| Sep 30, 2012 | -370.00 |
| Jun 30, 2012 | 148.00 |
| Mar 31, 2012 | -697.00 |
| Dec 31, 2011 | -458.00 |
| Sep 30, 2011 | 239.00 |